Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A-Reference-Cited by-同舟云学术

Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A

Published:2022-02-07 Issue:3 Volume:39 Page:663-673
ISSN:1058-0468
Container-title:Journal of Assisted Reproduction and Genetics
language:en
Short-container-title:J Assist Reprod Genet

Author:

Vaiarelli Alberto^ORCID,Cimadomo Danilo,Gennarelli Gianluca,Guido Maurizio,Alviggi Carlo,Conforti Alessandro,Livi Claudia,Revelli Alberto,Colamaria Silvia,Argento Cindy,Giuliani Maddalena,De Angelis Carlo,Matteo Maria,Canosa Stefano,D’Alfonso Angela,Cimadomo Valentino,Rienzi Laura,Ubaldi Filippo Maria

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Obstetrics and Gynecology,Genetics,Reproductive Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10815-022-02409-z.pdf

Reference50 articles.

1. Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. Poseidon Group. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452–3. https://doi.org/10.1016/j.fertnstert.2016.02.005. PubMed PMID: 26921622.

2. Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol (Lausanne). 2019;10:814. https://doi.org/10.3389/fendo.2019.00814.PubMedPMID:31824427;PubMedCentralPMCID:PMCPMC6880663.

3. Conforti A, Esteves SC, Cimadomo D, Vaiarelli A, Di Rella F, Ubaldi FM, et al. Management of women with an unexpected low ovarian response to gonadotropin. Front Endocrinol (Lausanne). 2019;10:387. https://doi.org/10.3389/fendo.2019.00387.PubMedPMID:31316461;PubMedCentralPMCID:PMCPMC6610322.

4. Esteves SC, Yarali H, Ubaldi FM, Carvalho JF, Bento FC, Vaiarelli A, et al. Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection. Front Endocrinol (Lausanne). 2019;10:917. https://doi.org/10.3389/fendo.2019.00917.PubMedPMID:32038484;PubMedCentralPMCID:PMCPMC6992582.

5. Vaiarelli A, Cimadomo D, Ubaldi N, Rienzi L, Ubaldi FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol. 2018;30(3):155–62. https://doi.org/10.1097/GCO.0000000000000452 (PubMed PMID: 29664789).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DuoStim: do we have enough evidence to use it?;Fertility and Sterility;2024-09

2. What protocol should not be adopted, and which patients should not be suggested double stimulation in the same ovarian cycle? A randomized controlled trial answers;Human Reproduction;2024-06-22

3. Investigating Ovulation Induction Outcomes in Patients with Decreased Ovarian Reserve Treated with Double Stimulation during The Follicular and Luteal Phases Compared to The Conventional Antagonist Cycle: A Randomized Clinical Trial;INT J FERTIL STERIL;2024

4. GnRH agonist trigger in poor prognosis patients undergoing a multicycle approach through DuoStim or consecutive stimulations: a SWOT analysis;Current Opinion in Obstetrics & Gynecology;2024-03-26

5. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial;Human Reproduction;2024-01-10